Last quarter (Q4 2023), Syros Pharmaceuticals's total revenue was $387.00K, a decrease of -151.33% from the same quarter last year. In Q4, Syros Pharmaceuticals's net income was $-64.38M. See Syros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 9.94M	$ 9.94M	$ 14.88M	$ 23.49M	$ 15.09M	$ 1.98M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 9.94M	$ 9.94M	$ 14.88M	$ 23.49M	-	-
Operating Expense	$ 138.92M	$ 138.92M	$ 150.75M	$ 122.91M	$ 97.39M	$ 79.72M
Operating Income	$ -128.99M	$ -128.99M	$ -135.87M	$ -99.42M	$ -82.30M	$ -77.74M
Net Non Operating Interest Income Expense	$ 1.69M	$ 1.69M	$ -2.00M	$ -3.82M	$ -1.37M	$ 2.30M
Other Income Expense	$ 37.27M	$ 37.27M	$ -43.22M	$ -16.68M	$ -375.00K	$ 2.30M
Pretax Income	$ -164.59M	$ -164.59M	$ -75.63M	$ -86.56M	$ -84.04M	$ -75.44M
Tax Provision	$ 1.00K	$ 1.00K	$ 3.00K	$ -1.00K	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -164.57M	$ -164.57M	$ -94.65M	$ -86.56M	$ -84.04M	$ -75.44M
Basic EPS	$ -5.76	$ -5.81	$ -7.49	-	$ -1.82	$ -1.88
Diluted EPS	$ -5.76	$ -5.81	$ -7.49	$ -13.80	$ -1.82	$ -1.88
Basic Average Shares	$ 113.30M	$ 28.33M	$ 12.63M	$ 6.25M	$ 46.05M	$ 40.22M
Diluted Average Shares	$ 113.30M	$ 28.33M	$ 12.63M	$ 6.25M	$ 46.05M	$ 40.22M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 138.92M	$ 138.92M	$ 150.75M	$ 122.91M	$ 97.39M	$ 79.72M
Net Income From Continuing And Discontinued Operation	$ -164.57M	$ -164.57M	$ -94.65M	$ -86.56M	$ -84.04M	$ -75.44M
Normalized Income	$ -107.73M	$ -126.52M	$ -59.75M	-	$ -83.66M	$ -75.44M
Interest Expense	-	-	-	-	$ 1.79M	$ 72.00K
EBIT	$ -159.46M	$ -159.46M	$ -71.50M	$ -82.65M	$ -82.25M	$ -75.37M
EBITDA	$ -157.90M	$ -157.90M	$ -67.60M	$ -78.66M	$ -79.21M	$ -72.64M

Currency in USD

Syros Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing